Bridget L. Morse
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Forensic Toxicology and Drug Analysis, Pharmacogenetics and Drug Metabolism, Alcohol Consumption and Health Effects, Pharmacological Effects and Toxicity Studies
Most-Cited Works
- → Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events(2016)171 cited
- → Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease(2015)91 cited
- → Characterization of Organic Anion Transporter 2 (SLC22A7): A Highly Efficient Transporter for Creatinine and Species-Dependent Renal Tubular Expression(2015)83 cited
- → γ-Hydroxybutyric Acid: Pharmacokinetics, Pharmacodynamics, and Toxicology(2021)80 cited
- → Identification and Characterization of Trimethylamine-N-oxide Uptake and Efflux Transporters(2016)72 cited
- → Predicting Clinical Effects of CYP3A4 Modulators on Abemaciclib and Active Metabolites Exposure Using Physiologically Based Pharmacokinetic Modeling(2020)50 cited
- → γ-Hydroxybutyrate (GHB)-Induced Respiratory Depression: Combined Receptor-Transporter Inhibition Therapy for Treatment in GHB Overdose(2012)49 cited
- → Concentration-Effect Relationships for the Drug of Abuse γ-Hydroxybutyric Acid(2010)45 cited
- → Utilization of OATP1B Biomarker Coproporphyrin‐I to Guide Drug–Drug Interaction Risk Assessment: Evaluation by the Pharmaceutical Industry(2023)39 cited
- → Pharmacokinetics of Organic Cation Transporter 1 (OCT1) Substrates in Oct1/2 Knockout Mice and Species Difference in Hepatic OCT1-Mediated Uptake(2019)33 cited